- Home
- GLMD vs ALBT Comparison
GLMD vs ALBT Comparison
Compare GLMD & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- ALBT
- Stock Information
- Founded
- GLMD 2000
- ALBT 2014
- Country
- GLMD Israel
- ALBT United States
- Employees
- GLMD N/A
- ALBT N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GLMD Health Care
- ALBT Health Care
- Exchange
- GLMD Nasdaq
- ALBT Nasdaq
- Market Cap
- GLMD 7.5M
- ALBT 7.4M
- IPO Year
- GLMD 2014
- ALBT N/A
- Fundamental
- Price
- GLMD $1.51
- ALBT $2.80
- Analyst Decision
- GLMD Hold
- ALBT
- Analyst Count
- GLMD 1
- ALBT 0
- Target Price
- GLMD N/A
- ALBT N/A
- AVG Volume (30 Days)
- GLMD 224.4K
- ALBT 75.9K
- Earning Date
- GLMD 08-28-2025
- ALBT 11-11-2025
- Dividend Yield
- GLMD N/A
- ALBT N/A
- EPS Growth
- GLMD N/A
- ALBT N/A
- EPS
- GLMD N/A
- ALBT N/A
- Revenue
- GLMD N/A
- ALBT $1,159,091.00
- Revenue This Year
- GLMD N/A
- ALBT N/A
- Revenue Next Year
- GLMD N/A
- ALBT N/A
- P/E Ratio
- GLMD N/A
- ALBT N/A
- Revenue Growth
- GLMD N/A
- ALBT N/A
- 52 Week Low
- GLMD $1.15
- ALBT $1.87
- 52 Week High
- GLMD $23.80
- ALBT $11.66
- Technical
- Relative Strength Index (RSI)
- GLMD 53.20
- ALBT 68.41
- Support Level
- GLMD $1.33
- ALBT $2.04
- Resistance Level
- GLMD $1.63
- ALBT $2.63
- Average True Range (ATR)
- GLMD 0.11
- ALBT 0.18
- MACD
- GLMD 0.03
- ALBT 0.09
- Stochastic Oscillator
- GLMD 69.23
- ALBT 89.37
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.